$DGX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in QUEST DIAGNOSTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in QUEST DIAGNOSTICS INC. Get notifications about new insider transactions in QUEST DIAGNOSTICS INC for free.
Page: < prev 1 ... 3 4 5 6 7 8 9 10 11 ... 18 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 12 2014 | DGX | QUEST DIAGNOSTICS ... | PFEIFFER GARY M | Director | Option Exercise | M | 48.02 | 10,000 | 480,225 | 0 | |
Nov 12 2014 | DGX | QUEST DIAGNOSTICS ... | PFEIFFER GARY M | Director | Sell | S | 61.69 | 10,000 | 616,900 | 16,851 | 26.9 K to 16.9 K (-37.24 %) |
Nov 12 2014 | DGX | QUEST DIAGNOSTICS ... | PFEIFFER GARY M | Director | Buy | M | 48.02 | 10,000 | 480,225 | 26,851 | 16.9 K to 26.9 K (+59.34 %) |
Nov 05 2014 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Physician Serv ... | Option Exercise | M | 47.49 | 23,667 | 1,123,946 | 0 | |
Nov 05 2014 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Physician Serv ... | Sell | S | 62.19 | 23,667 | 1,471,910 | 76,183 | 99.9 K to 76.2 K (-23.70 %) |
Nov 05 2014 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Physician Serv ... | Buy | M | 47.49 | 23,667 | 1,123,946 | 99,850 | 76.2 K to 99.9 K (+31.07 %) |
Aug 20 2014 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Senior Vice Preside ... | Payment of Exercise | F | 61.99 | 639 | 39,612 | 41,189 | 41.8 K to 41.2 K (-1.53 %) |
Aug 20 2014 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Senior Vice Preside ... | Payment of Exercise | F | 61.99 | 2,394 | 148,404 | 41,828 | 44.2 K to 41.8 K (-5.41 %) |
Aug 11 2014 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Option Exercise | M | 53.19 | 25,000 | 1,329,750 | 0 | |
Aug 11 2014 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Sell | S | 60.12 | 25,000 | 1,502,900 | 76,171 | 101.2 K to 76.2 K (-24.71 %) |
Aug 11 2014 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Buy | M | 53.19 | 25,000 | 1,329,750 | 101,157 | 76.2 K to 101.2 K (+32.83 %) |
Aug 05 2014 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Option Exercise | M | 47.49 | 14,377 | 682,764 | 0 | |
Aug 05 2014 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 61.01 | 14,377 | 877,182 | 43,330 | 57.7 K to 43.3 K (-24.91 %) |
Aug 05 2014 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Buy | M | 47.49 | 14,377 | 682,764 | 57,700 | 43.3 K to 57.7 K (+33.19 %) |
Jul 31 2014 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Option Exercise | M | 47.49 | 16,384 | 778,076 | 14,377 | |
Jul 31 2014 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 62.51 | 16,384 | 1,024,103 | 43,323 | 59.7 K to 43.3 K (-27.44 %) |
Jul 31 2014 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Buy | M | 47.49 | 16,384 | 778,076 | 59,596 | 43.2 K to 59.6 K (+37.92 %) |
Jul 31 2014 | DGX | QUEST DIAGNOSTICS ... | BRITELL JENNE K | Director | Option Exercise | M | 49.94 | 8,000 | 399,520 | 0 | |
Jul 31 2014 | DGX | QUEST DIAGNOSTICS ... | BRITELL JENNE K | Director | Sell | S | 62.37 | 8,000 | 498,960 | 15,151 | 23.2 K to 15.2 K (-34.56 %) |
Jul 31 2014 | DGX | QUEST DIAGNOSTICS ... | BRITELL JENNE K | Director | Buy | M | 49.94 | 8,000 | 399,520 | 23,151 | 15.2 K to 23.2 K (+52.80 %) |
Jul 29 2014 | DGX | QUEST DIAGNOSTICS ... | BALDWIN JOHN C MD | Director | Option Exercise | M | 55.76 | 8,000 | 446,080 | 0 | |
Jul 29 2014 | DGX | QUEST DIAGNOSTICS ... | BALDWIN JOHN C MD | Director | Sell | S | 62.31 | 8,000 | 498,480 | 12,875 | 20.9 K to 12.9 K (-38.32 %) |
Jul 29 2014 | DGX | QUEST DIAGNOSTICS ... | BALDWIN JOHN C MD | Director | Buy | M | 55.76 | 8,000 | 446,080 | 20,875 | 12.9 K to 20.9 K (+62.14 %) |
Jul 28 2014 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Option Exercise | M | 49.94 | 1,865 | 93,138 | 0 | |
Jul 28 2014 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Option Exercise | M | 49.94 | 6,135 | 306,382 | 1,865 | |
Jul 28 2014 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Sell | S | 61.90 | 1,865 | 115,444 | 16,825 | 18.7 K to 16.8 K (-9.98 %) |
Jul 28 2014 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Buy | M | 49.94 | 1,865 | 93,138 | 18,690 | 16.8 K to 18.7 K (+11.08 %) |
Jul 28 2014 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Sell | S | 61.90 | 6,135 | 379,757 | 16,825 | 23 K to 16.8 K (-26.72 %) |
Jul 28 2014 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Buy | M | 49.94 | 6,135 | 306,382 | 22,960 | 16.8 K to 23 K (+36.46 %) |
Jul 29 2014 | DGX | QUEST DIAGNOSTICS ... | BONGIORNO THOMAS F | VP and Corporate Co ... | Option Exercise | M | 53.19 | 4,000 | 212,760 | 0 | |
Jul 29 2014 | DGX | QUEST DIAGNOSTICS ... | BONGIORNO THOMAS F | VP and Corporate Co ... | Sell | S | 61.72 | 4,000 | 246,869 | 15,187 | 19.2 K to 15.2 K (-20.85 %) |
Jul 29 2014 | DGX | QUEST DIAGNOSTICS ... | BONGIORNO THOMAS F | VP and Corporate Co ... | Buy | M | 53.19 | 4,000 | 212,760 | 19,065 | 15.1 K to 19.1 K (+26.55 %) |
Jul 24 2014 | DGX | QUEST DIAGNOSTICS ... | Gregg Vicky B | Director | Grant | A | 0.00 | 2,283 | 0 | 2,283 | 0 to 2.3 K |
May 22 2014 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Option Exercise | M | 47.94 | 998 | 47,842 | 0 | |
May 22 2014 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Sell | S | 57.65 | 1,975 | 113,855 | 16,825 | 18.8 K to 16.8 K (-10.51 %) |
May 22 2014 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Sell | S | 57.66 | 998 | 57,547 | 18,800 | 19.8 K to 18.8 K (-5.04 %) |
May 22 2014 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Buy | M | 47.94 | 998 | 47,842 | 19,798 | 18.8 K to 19.8 K (+5.31 %) |
May 22 2014 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Grant | A | 0.00 | 2,924 | 0 | 18,800 | 15.9 K to 18.8 K (+18.42 %) |
May 22 2014 | DGX | QUEST DIAGNOSTICS ... | WILENSKY GAIL R | Director | Grant | A | 0.00 | 2,924 | 0 | 18,851 | 15.9 K to 18.9 K (+18.36 %) |
May 22 2014 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Grant | A | 0.00 | 4,186 | 0 | 26,337 | 22.2 K to 26.3 K (+18.90 %) |
May 22 2014 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Grant | A | 0.00 | 2,924 | 0 | 7,697 | 4.8 K to 7.7 K (+61.26 %) |
May 22 2014 | DGX | QUEST DIAGNOSTICS ... | PFEIFFER GARY M | Director | Grant | A | 0.00 | 2,924 | 0 | 16,851 | 13.9 K to 16.9 K (+21.00 %) |
May 22 2014 | DGX | QUEST DIAGNOSTICS ... | MAIN TIMOTHY L | Director | Grant | A | 0.00 | 2,924 | 0 | 8,582 | 5.7 K to 8.6 K (+51.68 %) |
May 22 2014 | DGX | QUEST DIAGNOSTICS ... | BRITELL JENNE K | Director | Grant | A | 0.00 | 2,924 | 0 | 15,151 | 12.2 K to 15.2 K (+23.91 %) |
May 22 2014 | DGX | QUEST DIAGNOSTICS ... | BALDWIN JOHN C MD | Director | Grant | A | 0.00 | 2,924 | 0 | 12,875 | 10 K to 12.9 K (+29.38 %) |
May 22 2014 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | SVP, Operations | Payment of Exercise | F | 57.33 | 2,183 | 125,140 | 20,506 | 22.7 K to 20.5 K (-9.62 %) |
May 21 2014 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Payment of Exercise | F | 57.72 | 551 | 31,804 | 76,157 | 76.7 K to 76.2 K (-0.72 %) |
May 09 2014 | DGX | QUEST DIAGNOSTICS ... | PFEIFFER GARY M | Director | Option Exercise | M | 49.04 | 10,000 | 490,400 | 0 | |
May 09 2014 | DGX | QUEST DIAGNOSTICS ... | PFEIFFER GARY M | Director | Sell | S | 55.95 | 10,000 | 559,511 | 13,927 | 23.9 K to 13.9 K (-41.79 %) |
May 09 2014 | DGX | QUEST DIAGNOSTICS ... | PFEIFFER GARY M | Director | Buy | M | 49.04 | 10,000 | 490,400 | 23,927 | 13.9 K to 23.9 K (+71.80 %) |
May 07 2014 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Senior Vice Preside ... | Buy | P | 55.51 | 4,000 | 222,023 | 44,222 | 40.2 K to 44.2 K (+9.94 %) |
May 05 2014 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | President and CEO | Payment of Exercise | F | 56.02 | 2,987 | 167,332 | 110,362 | 113.3 K to 110.4 K (-2.64 %) |
May 02 2014 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Option Exercise | M | 49.04 | 10,000 | 490,400 | 0 | |
May 02 2014 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Option Exercise | M | 42.63 | 20,000 | 852,500 | 0 | |
May 02 2014 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Sell | S | 55.75 | 30,000 | 1,672,374 | 22,151 | 52.2 K to 22.2 K (-57.53 %) |
May 02 2014 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Buy | M | 49.04 | 10,000 | 490,400 | 52,151 | 42.2 K to 52.2 K (+23.72 %) |
May 02 2014 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Buy | M | 42.63 | 20,000 | 852,500 | 42,151 | 22.2 K to 42.2 K (+90.29 %) |
Apr 17 2014 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | President and CEO | Payment of Exercise | F | 60.03 | 3,814 | 228,935 | 113,079 | 116.9 K to 113.1 K (-3.26 %) |
Mar 05 2014 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 53.00 | 778 | 41,233 | 43,212 | 44 K to 43.2 K (-1.77 %) |
Mar 03 2014 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Payment of Exercise | F | 52.92 | 463 | 24,500 | 43,981 | 44.4 K to 44 K (-1.04 %) |
Mar 03 2014 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Payment of Exercise | F | 52.92 | 661 | 34,977 | 76,685 | 77.3 K to 76.7 K (-0.85 %) |
Mar 03 2014 | DGX | QUEST DIAGNOSTICS ... | BONGIORNO THOMAS F | VP and Corporate Co ... | Payment of Exercise | F | 52.92 | 172 | 9,101 | 15,065 | 15.2 K to 15.1 K (-1.13 %) |
Mar 03 2014 | DGX | QUEST DIAGNOSTICS ... | Cohen Jon R | SVP and Chief Medic ... | Payment of Exercise | F | 52.92 | 617 | 32,649 | 59,131 | 59.7 K to 59.1 K (-1.03 %) |
Feb 28 2014 | DGX | QUEST DIAGNOSTICS ... | BRITELL JENNE K | Director | Option Exercise | M | 49.04 | 10,000 | 490,400 | 0 | |
Feb 28 2014 | DGX | QUEST DIAGNOSTICS ... | BRITELL JENNE K | Director | Sell | S | 52.74 | 10,000 | 527,393 | 12,227 | 22.2 K to 12.2 K (-44.99 %) |
Feb 28 2014 | DGX | QUEST DIAGNOSTICS ... | BRITELL JENNE K | Director | Buy | M | 49.04 | 10,000 | 490,400 | 22,227 | 12.2 K to 22.2 K (+81.79 %) |
Feb 27 2014 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | President and CEO | Payment of Exercise | F | 53.34 | 2,531 | 135,004 | 116,553 | 119.1 K to 116.6 K (-2.13 %) |
Feb 27 2014 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 52.99 | 827 | 43,826 | 44,444 | 45.3 K to 44.4 K (-1.83 %) |
Feb 27 2014 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Payment of Exercise | F | 53.34 | 491 | 26,190 | 45,271 | 45.8 K to 45.3 K (-1.07 %) |
Feb 27 2014 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Payment of Exercise | F | 53.34 | 661 | 35,258 | 77,346 | 78 K to 77.3 K (-0.85 %) |
Feb 27 2014 | DGX | QUEST DIAGNOSTICS ... | Cunningham Everett | SVP, Commercial | Payment of Exercise | F | 53.34 | 665 | 35,471 | 24,776 | 25.4 K to 24.8 K (-2.61 %) |
Feb 27 2014 | DGX | QUEST DIAGNOSTICS ... | Cohen Jon R | SVP and Chief Medic ... | Payment of Exercise | F | 53.34 | 661 | 35,258 | 59,748 | 60.4 K to 59.7 K (-1.09 %) |
Feb 27 2014 | DGX | QUEST DIAGNOSTICS ... | BONGIORNO THOMAS F | VP and Corporate Co ... | Payment of Exercise | F | 53.34 | 177 | 9,441 | 15,237 | 15.4 K to 15.2 K (-1.15 %) |
Feb 20 2014 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 52.26 | 2,860 | 149,472 | 45,762 | 48.6 K to 45.8 K (-5.88 %) |
Feb 19 2014 | DGX | QUEST DIAGNOSTICS ... | WILENSKY GAIL R | Director | Option Exercise | M | 49.04 | 10,000 | 490,400 | 0 | |
Feb 19 2014 | DGX | QUEST DIAGNOSTICS ... | WILENSKY GAIL R | Director | Option Exercise | M | 42.63 | 20,000 | 852,500 | 0 | |
Feb 19 2014 | DGX | QUEST DIAGNOSTICS ... | WILENSKY GAIL R | Director | Sell | S | 52.95 | 10,000 | 529,457 | 15,927 | 25.9 K to 15.9 K (-38.57 %) |
Feb 19 2014 | DGX | QUEST DIAGNOSTICS ... | WILENSKY GAIL R | Director | Sell | S | 52.93 | 20,000 | 1,058,584 | 25,927 | 45.9 K to 25.9 K (-43.55 %) |
Feb 19 2014 | DGX | QUEST DIAGNOSTICS ... | WILENSKY GAIL R | Director | Buy | M | 49.04 | 10,000 | 490,400 | 45,927 | 35.9 K to 45.9 K (+27.83 %) |
Feb 19 2014 | DGX | QUEST DIAGNOSTICS ... | WILENSKY GAIL R | Director | Buy | M | 42.63 | 20,000 | 852,500 | 35,927 | 15.9 K to 35.9 K (+125.57 %) |
Feb 18 2014 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | President and CEO | Option Exercise | A | 52.17 | 244,565 | 12,757,733 | 244,565 | |
Feb 18 2014 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | President and CEO | Grant | A | 0.00 | 25,688 | 0 | 119,084 | 93.4 K to 119.1 K (+27.50 %) |
Feb 18 2014 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Option Exercise | A | 52.17 | 47,454 | 2,475,438 | 47,454 | |
Feb 18 2014 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Payment of Exercise | F | 52.56 | 1,737 | 91,288 | 48,622 | 50.4 K to 48.6 K (-3.45 %) |
Feb 18 2014 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Grant | A | 0.00 | 4,985 | 0 | 50,291 | 45.3 K to 50.3 K (+11.00 %) |
Feb 18 2014 | DGX | QUEST DIAGNOSTICS ... | Haydon John B. | SVP, Operations | Option Exercise | A | 52.17 | 5,476 | 285,656 | 5,476 | |
Feb 18 2014 | DGX | QUEST DIAGNOSTICS ... | Haydon John B. | SVP, Operations | Grant | A | 0.00 | 576 | 0 | 19,890 | 19.3 K to 19.9 K (+2.98 %) |
Feb 18 2014 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Senior Vice Preside ... | Option Exercise | A | 52.17 | 73,005 | 3,808,306 | 73,005 | |
Feb 18 2014 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Senior Vice Preside ... | Grant | A | 0.00 | 7,668 | 0 | 40,222 | 32.6 K to 40.2 K (+23.55 %) |
Feb 18 2014 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Option Exercise | A | 52.17 | 63,880 | 3,332,300 | 63,880 | |
Feb 18 2014 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Payment of Exercise | F | 52.56 | 1,441 | 75,732 | 78,007 | 79.4 K to 78 K (-1.81 %) |
Feb 18 2014 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Grant | A | 0.00 | 6,710 | 0 | 79,005 | 72.3 K to 79 K (+9.28 %) |
Feb 18 2014 | DGX | QUEST DIAGNOSTICS ... | Cunningham Everett | SVP, Commercial | Option Exercise | A | 52.17 | 63,880 | 3,332,300 | 63,880 | |
Feb 18 2014 | DGX | QUEST DIAGNOSTICS ... | Cunningham Everett | SVP, Commercial | Grant | A | 0.00 | 6,710 | 0 | 25,441 | 18.7 K to 25.4 K (+35.82 %) |
Feb 18 2014 | DGX | QUEST DIAGNOSTICS ... | Cohen Jon R | SVP and Chief Medic ... | Option Exercise | A | 52.17 | 63,880 | 3,332,300 | 63,880 | |
Feb 18 2014 | DGX | QUEST DIAGNOSTICS ... | Cohen Jon R | SVP and Chief Medic ... | Payment of Exercise | F | 52.56 | 2,290 | 120,351 | 60,409 | 62.7 K to 60.4 K (-3.65 %) |
Feb 18 2014 | DGX | QUEST DIAGNOSTICS ... | Cohen Jon R | SVP and Chief Medic ... | Grant | A | 0.00 | 6,710 | 0 | 60,942 | 54.2 K to 60.9 K (+12.37 %) |
Feb 18 2014 | DGX | QUEST DIAGNOSTICS ... | BONGIORNO THOMAS F | VP and Corporate Co ... | Option Exercise | A | 52.17 | 16,427 | 856,914 | 16,427 | |
Feb 18 2014 | DGX | QUEST DIAGNOSTICS ... | BONGIORNO THOMAS F | VP and Corporate Co ... | Sell | D | 52.55 | 630 | 33,107 | 15,414 | 16 K to 15.4 K (-3.93 %) |
Feb 18 2014 | DGX | QUEST DIAGNOSTICS ... | BONGIORNO THOMAS F | VP and Corporate Co ... | Grant | A | 0.00 | 1,726 | 0 | 15,923 | 14.2 K to 15.9 K (+12.16 %) |
Feb 14 2014 | DGX | QUEST DIAGNOSTICS ... | BUEHLER WILLIAM F | Director | Option Exercise | M | 49.04 | 10,000 | 490,400 | 0 | |
Feb 14 2014 | DGX | QUEST DIAGNOSTICS ... | BUEHLER WILLIAM F | Director | Option Exercise | M | 42.63 | 20,000 | 852,500 | 0 | |
Feb 14 2014 | DGX | QUEST DIAGNOSTICS ... | BUEHLER WILLIAM F | Director | Sell | S | 52.15 | 30,000 | 1,564,449 | 26,225 | 56.2 K to 26.2 K (-53.36 %) |
Feb 14 2014 | DGX | QUEST DIAGNOSTICS ... | BUEHLER WILLIAM F | Director | Buy | M | 49.04 | 10,000 | 490,400 | 56,225 | 46.2 K to 56.2 K (+21.63 %) |
Feb 14 2014 | DGX | QUEST DIAGNOSTICS ... | BUEHLER WILLIAM F | Director | Buy | M | 42.63 | 20,000 | 852,500 | 46,225 | 26.2 K to 46.2 K (+76.26 %) |
Feb 07 2014 | DGX | QUEST DIAGNOSTICS ... | MAIN TIMOTHY L | Director | Buy | P | 50.71 | 2,600 | 131,846 | 5,658 | 3.1 K to 5.7 K (+85.02 %) |
Feb 07 2014 | DGX | QUEST DIAGNOSTICS ... | MAIN TIMOTHY L | Director | Buy | P | 50.70 | 2,400 | 121,680 | 3,058 | 658 to 3.1 K (+364.74 %) |
Jan 14 2014 | DGX | QUEST DIAGNOSTICS ... | MAIN TIMOTHY L | Director | Option Exercise | A | 53.73 | 2,037 | 109,438 | 2,037 | |
Jan 14 2014 | DGX | QUEST DIAGNOSTICS ... | MAIN TIMOTHY L | Director | Grant | A | 0.00 | 658 | 0 | 658 | 0 to 658 |
Jan 06 2014 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Option Exercise | A | 53.13 | 1,053 | 55,941 | 1,053 | |
Dec 17 2013 | DGX | QUEST DIAGNOSTICS ... | Haydon John B. | SVP, Operations | Payment of Exercise | F | 54.15 | 4,720 | 255,588 | 19,058 | 23.8 K to 19.1 K (-19.85 %) |
Dec 17 2013 | DGX | QUEST DIAGNOSTICS ... | Cunningham Everett | SVP, Commercial | Payment of Exercise | F | 54.15 | 2,376 | 128,660 | 18,514 | 20.9 K to 18.5 K (-11.37 %) |
Nov 13 2013 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Option Exercise | M | 47.49 | 24,239 | 1,151,110 | 30,761 | |
Nov 13 2013 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 64.02 | 24,239 | 1,551,686 | 45,306 | 69.5 K to 45.3 K (-34.85 %) |
Nov 13 2013 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Buy | M | 47.49 | 24,239 | 1,151,110 | 69,430 | 45.2 K to 69.4 K (+53.64 %) |
Nov 05 2013 | DGX | QUEST DIAGNOSTICS ... | BONGIORNO THOMAS F | VP and Corporate Co ... | Option Exercise | M | 52.25 | 8,000 | 417,960 | 0 | |
Nov 05 2013 | DGX | QUEST DIAGNOSTICS ... | BONGIORNO THOMAS F | VP and Corporate Co ... | Option Exercise | M | 52.25 | 8,667 | 452,807 | 8,000 | |
Nov 05 2013 | DGX | QUEST DIAGNOSTICS ... | BONGIORNO THOMAS F | VP and Corporate Co ... | Sell | S | 63.00 | 8,000 | 504,000 | 14,197 | 22.2 K to 14.2 K (-36.04 %) |
Nov 05 2013 | DGX | QUEST DIAGNOSTICS ... | BONGIORNO THOMAS F | VP and Corporate Co ... | Buy | M | 52.25 | 8,000 | 417,960 | 22,167 | 14.2 K to 22.2 K (+56.47 %) |
Nov 05 2013 | DGX | QUEST DIAGNOSTICS ... | BONGIORNO THOMAS F | VP and Corporate Co ... | Sell | S | 62.02 | 8,667 | 537,508 | 14,167 | 22.8 K to 14.2 K (-37.96 %) |
Nov 05 2013 | DGX | QUEST DIAGNOSTICS ... | BONGIORNO THOMAS F | VP and Corporate Co ... | Buy | M | 52.25 | 8,667 | 452,807 | 22,834 | 14.2 K to 22.8 K (+61.18 %) |
Nov 05 2013 | DGX | QUEST DIAGNOSTICS ... | BALDWIN JOHN C MD | Director | Sell | S | 63.00 | 658 | 41,454 | 9,951 | 10.6 K to 10 K (-6.20 %) |
Nov 04 2013 | DGX | QUEST DIAGNOSTICS ... | BALDWIN JOHN C MD | Director | Option Exercise | M | 51.55 | 8,000 | 412,400 | 0 | |
Nov 04 2013 | DGX | QUEST DIAGNOSTICS ... | BALDWIN JOHN C MD | Director | Sell | S | 59.70 | 8,000 | 477,600 | 10,609 | 18.6 K to 10.6 K (-42.99 %) |
Nov 04 2013 | DGX | QUEST DIAGNOSTICS ... | BALDWIN JOHN C MD | Director | Buy | M | 51.55 | 8,000 | 412,400 | 18,609 | 10.6 K to 18.6 K (+75.41 %) |
Oct 30 2013 | DGX | QUEST DIAGNOSTICS ... | BONGIORNO THOMAS F | VP and Corporate Co ... | Option Exercise | M | 40.43 | 6,000 | 242,565 | 0 | |
Oct 30 2013 | DGX | QUEST DIAGNOSTICS ... | BONGIORNO THOMAS F | VP and Corporate Co ... | Sell | S | 59.00 | 6,000 | 354,000 | 14,167 | 20.2 K to 14.2 K (-29.75 %) |
Oct 30 2013 | DGX | QUEST DIAGNOSTICS ... | BONGIORNO THOMAS F | VP and Corporate Co ... | Buy | M | 40.43 | 6,000 | 242,565 | 20,086 | 14.1 K to 20.1 K (+42.60 %) |
Oct 25 2013 | DGX | QUEST DIAGNOSTICS ... | PFEIFFER GARY M | Director | Sell | S | 58.10 | 2,000 | 116,200 | 13,927 | 15.9 K to 13.9 K (-12.56 %) |
Oct 03 2013 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Option Exercise | A | 62.01 | 1,341 | 83,155 | 1,341 | |
Sep 18 2013 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Option Exercise | M | 52.25 | 27,621 | 1,443,059 | 0 | |
Sep 18 2013 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Option Exercise | M | 52.25 | 15,713 | 820,926 | 27,621 | |
Sep 18 2013 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Sell | S | 62.00 | 27,621 | 1,712,502 | 72,295 | 99.9 K to 72.3 K (-27.64 %) |
Sep 18 2013 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Buy | M | 52.25 | 27,621 | 1,443,059 | 99,911 | 72.3 K to 99.9 K (+38.21 %) |
Sep 18 2013 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Sell | S | 62.00 | 15,713 | 974,206 | 72,290 | 88 K to 72.3 K (-17.86 %) |
Sep 18 2013 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Buy | M | 52.25 | 15,713 | 820,926 | 88,003 | 72.3 K to 88 K (+21.74 %) |
Aug 21 2013 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Senior Vice Preside ... | Option Exercise | A | 58.37 | 61,533 | 3,591,374 | 61,533 | |
Aug 21 2013 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Senior Vice Preside ... | Grant | A | 0.00 | 25,700 | 0 | 32,554 | 6.9 K to 32.6 K (+374.96 %) |
Aug 21 2013 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Senior Vice Preside ... | Grant | A | 0.00 | 6,854 | 0 | 6,854 | 0 to 6.9 K |
Aug 15 2013 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Option Exercise | M | 40.43 | 33,000 | 1,334,108 | 0 | |
Aug 15 2013 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Sell | S | 59.85 | 33,000 | 1,975,126 | 72,290 | 105.3 K to 72.3 K (-31.34 %) |
Aug 15 2013 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Buy | M | 40.43 | 33,000 | 1,334,108 | 105,079 | 72.1 K to 105.1 K (+45.78 %) |
Aug 12 2013 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Sell | S | 59.45 | 1,953 | 116,109 | 15,876 | 17.8 K to 15.9 K (-10.95 %) |
Aug 12 2013 | DGX | QUEST DIAGNOSTICS ... | BONGIORNO THOMAS F | VP and Corporate Co ... | Option Exercise | M | 40.43 | 12,000 | 485,130 | 6,000 | |
Aug 12 2013 | DGX | QUEST DIAGNOSTICS ... | BONGIORNO THOMAS F | VP and Corporate Co ... | Sell | S | 59.33 | 10,864 | 644,585 | 14,086 | 25 K to 14.1 K (-43.54 %) |
Aug 12 2013 | DGX | QUEST DIAGNOSTICS ... | BONGIORNO THOMAS F | VP and Corporate Co ... | Buy | M | 40.43 | 12,000 | 485,130 | 24,770 | 12.8 K to 24.8 K (+93.97 %) |
Jul 03 2013 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Option Exercise | A | 60.79 | 1,371 | 83,336 | 1,371 | |
Jul 25 2013 | DGX | QUEST DIAGNOSTICS ... | BRITELL JENNE K | Director | Sell | S | 58.99 | 4,200 | 247,767 | 12,227 | 16.4 K to 12.2 K (-25.57 %) |
Jun 19 2013 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Option Exercise | M | 40.43 | 9,921 | 401,081 | 0 | |
Jun 19 2013 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Option Exercise | M | 52.25 | 54,667 | 2,856,077 | 0 |